Cost-effectiveness Analysis of Therapeutic schemes for Peptic Ulcer With Helicobacteria Pylori / 中国药房

ABSTRACT

OBJECTIVE:To evaluate the economic effectiveness of different pharmacotherapeutic schemes for the same disease Three therapeutic schemes(including A,B and C schemes)for peptic ulcer with Helicobacteria pylori were compared METHODS:The schemes were evaluated with pharmacoeconomic cost-effectiveness analysis RESULTS:The results showed that B was the best scheme from either cost-effectiveness analysis(C/E)or increasing costeffectiveness analysis(?C/?E) CONCLUSION:Pharmacoeconomics is very important in optimizing therapeutic scheme,guiding rational drug use and in_creasing economic effectiveness